The historical rank and industry rank for Shree Ganesh Biotech (India)'s Net Margin % or its related term are showing as below:
BOM:539470'
s Net Margin % Range Over the Past 10 Years
Min: 1.21 Med: 5.54 Max: 44.55
Current: 10.34
BOM:539470's Net Margin % is ranked better than 79.12% of 249
companies
in the Agriculture industry
Industry Median: 4.16
vs BOM:539470: 10.34
Shree Ganesh Biotech (India) (BOM:539470) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Shree Ganesh Biotech (India) Net Margin % Related Terms
Shree Ganesh Biotech (India) Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:539470 vs CTVA, CF, MOS: Net Margin % Comparison
For the Agricultural Inputs subindustry, Shree Ganesh Biotech (India)'s Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shree Ganesh Biotech (India) Net Margin % vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Shree Ganesh Biotech (India)'s Net Margin % distribution charts can be found below:
* The bar in red indicates where Shree Ganesh Biotech (India)'s Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shree Ganesh Biotech (India) (BOM:539470) has a Net Margin % of -7.04% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Shree Ganesh Biotech (India) and its competitors. Over the past decade, Shree Ganesh Biotech (India)'s Net Margin % has ranged from 1.21 to 44.55. According to the industry distribution chart, Shree Ganesh Biotech (India) ranks #52 out of 249 companies in the Agriculture industry, placing it in the top 20.9%.
Is Shree Ganesh Biotech (India)'s Net Margin % too high?
Shree Ganesh Biotech (India)'s current Net Margin % is -7.04%. Over the past 10 years, this metric has ranged from a low of 1.21 to a high of 44.55. Based on the distribution chart, Shree Ganesh Biotech (India) ranks #52 out of 249 companies in the Agriculture industry, which is in the top quartile — a strong position relative to peers. Overall, Shree Ganesh Biotech (India) has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shree Ganesh Biotech (India)'s Net Margin % compare to CTVA and CF?
According to the Agriculture industry distribution chart, Shree Ganesh Biotech (India) ranks #52 out of 249 companies for Net Margin %. This places Shree Ganesh Biotech (India) in the top 21% of its industry — outperforming the majority of peers. The industry median Net Margin % is 4.16. Historically, Shree Ganesh Biotech (India)'s own Net Margin % has ranged from 1.21 to 44.55 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for an Agriculture company?
The median Net Margin % among Agriculture companies is 4.16, based on 249 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Shree Ganesh Biotech (India) and its competitors. For the Agriculture industry, the median Net Margin % is 4.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shree Ganesh Biotech (India)'s current Net Margin % is -7.04%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shree Ganesh Biotech (India) stock overvalued right now?
Based on GuruFocus' analysis, Shree Ganesh Biotech (India) (BOM:539470) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹0.20, compared to a current price of ₹0.56 — trading 180% above its estimated fair value. The current Net Margin % is -7.04%. Shree Ganesh Biotech (India)'s overall GF Score™ is 46/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Shree Ganesh Biotech (India) (BOM:539470), the current Net Margin % is -7.04% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shree Ganesh Biotech (India) (BOM:539470) Overvalued in 2026?
Based on GuruFocus' analysis, Shree Ganesh Biotech (India) stock appears to be overvalued.
The current stock price of ₹0.56 is trading 180% above its estimated GF Value™ of ₹0.20.
GuruFocus considers Shree Ganesh Biotech (India) to be Significantly Overvalued.
Key valuation signals for BOM:539470:
Net Margin %: -7.04%
GF Value™: ₹0.20 vs. price of ₹0.56 (180% above fair value)
No single metric tells the full story. See the BOM:539470 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shree Ganesh Biotech (India) Ltd is an India-based company mainly engaged in the business of production, processing and marketing of high-quality hybrid seeds for different crops like corn, sunflower, cotton, paddy, grain sorghum, etc.
46GF Score
Get the complete analysis for BOM:539470
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:539470 has been successfully added to your 
